Table 2.
Sites of infection and associated mortality among identified cases of mucormycosis in South America
| Site of infection | Brazil | Other South American countries | Total | |||
|---|---|---|---|---|---|---|
|
Incidence (N = 59) n (%) |
Mortality n (%)a |
Incidence (N = 84) n (%) |
Mortality n (%)a |
Incidence (N = 143) n (%) |
Mortality n (%)a |
|
| Rhino‐sino‐orbito‐cerebral | 22 (37.3) | 10 (45.5) | 42 (50.0) | 20 (47.6) | 64 (44.8) | 30 (46.9) |
| Pulmonary | 14 (23.7) | 10 (71.4) | 3 (3.6) | 1 (33.3) | 17 (11.9) | 11 (64.7) |
| Skin and soft tissues | 6 (10.2) | 0 (0) | 28 (33.3) | 11 (39.3) | 34b (23.8) | 11 (32.4) |
| Gastrointestinal or peritoneum | 4 (6.8) | 3 (75.0) | 1 (1.2) | 1 (100.0) | 5 (3.5) | 4 (80.0) |
| Liver or kidneys | 3 (5.1) | 0 (0) | 0 (0) | NA | 3 (2.1) | 0 (0) |
| Other | 3 (5.1) | 2 (66.7) | 5 (6.0) | 1 (20.0) | 8c (5.6) | 3 (37.5) |
| Disseminated infectiond | 7 (11.9) | 6 (85.7) | 5 (6.0) | 4 (80.0) | 12 (8.4) | 10 (83.3) |
Abbreviation: NA, not applicable.
a
Percentages are numbers of patients with the site of infection who died/total numbers with the site of infection.
b
Includes lower extremity (n = 10), trunk (10), upper extremity (5), head/face (5), lower extremity and trunk (2) and unknown (2).
c
Includes bone (4), central nervous system (2), endophthalmitis after cataract surgery (1) and oral cavity (1).
d
More than one non‐contiguous site.